Fat mass to fat-free mass ratio, a new measure of sarcopenic obesity Sarcopenic obesity is a progressive geriatric syndrome characterized by decreasing muscle mass and function... Learn More
The longitudinal, prospective association between diabetes and frailty among middle-aged and older adults in Canada Diabetes mellitus (DM) is a chronic disease that affects 10% of Canadians. It classically... Learn More
Diabetic ketoacidosis from new use of an SGLT2i: can genomics accurately estimate risk (DANGER) Sodium glucose co-transporter 2 inhibitors (SGLT2i) are medications that have revolutionized care for people... Learn More
Impact of the COVID-19 pandemic on obesity and diabetes in adults: a longitudinal study of participants of the Canadian Longitudinal Study on Aging (CLSA) Learn More
Diabetes mellitus-related hearing loss prevalence and association between hyperglycemia and hearing loss in adults participating in the Canadian Longitudinal Study of Aging Learn More
Enabling precision management of ophthalmic disease through discovery of underlying biological pathways and clinical prediction tool development Learn More
Behavioural and genetic risk factors associated with the risk of progression from prediabetes to diabetes in older adults: a longitudinal analysis of data from the Canadian Longitudinal Study on Aging (CLSA) Learn More
Biomarkers associated with infections in Canadians 45-85 years of age with and without diabetes: analysis of metabolomic, genetic and clinical data from the Canadian Longitudinal Study on Aging Learn More
Investigating 24-hour movement behavior and its impacts on the health of older Canadians: a Canadian Longitudinal Study on Aging (CLSA) study Learn More
